Skip to content
    SFPIM logo

    SFPIM

    Brussels, BelgiumFounded 2006

    SFPIM (Société Fédérale de Participations et d'Investissement) is Belgium's federal holding and investment company, often described as the country's sovereign wealth fund. It manages the Belgian federal government's shareholdings, invests in companies with strategic socio-economic value, and provides smart capital to Belgian SMEs and scale-ups across life sciences, finance, aviation, energy, and mobility.

    Deal activity increased 150% year-over-year (5 deals in the last 12 months). Average disclosed round size is $90.2M (across 12 rounds with reported amounts).

    Find people at SFPIM on Goldilocks AI

    Portfolio

    24

    Fund Size

    $18B

    Top Stage

    Series A

    Last 12 Mo

    5

    Team

    CT

    Christophe Tits

    HR Business Partner

    Adrien Gassée

    Adrien Gassée

    Financial Analyst

    MV

    Michiel Verheyden

    Investment analyst

    Alan Vandenberghe

    Alan Vandenberghe

    Investment Manager

    Barbara Reypens

    Barbara Reypens

    Investment Manager

    Céline Vaessen

    Céline Vaessen

    Chief investment officer

    Christophe Denis

    Christophe Denis

    Investment Manager

    Christophe Madam

    Christophe Madam

    Investment Manager

    Denis Ronday

    Denis Ronday

    Investment Manager

    Elisa Spadaro

    Elisa Spadaro

    Investment Manager

    Etienne Lauwereys

    Etienne Lauwereys

    Investment Manager

    FF

    François Fontaine

    Investment Manager

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    31 investments
    CompanyRoundAmountDate
    e-Peas logoe-PeasSeed$22MJul 2026
    Axelera AI logoAxelera AISeries C—Feb 2026
    AAidoptationUnknown—Dec 2025
    Resortecs logoResortecsSeries A—Nov 2025
    MRM Health logoMRM HealthSeries B—Sep 2025
    Swave Photonics logoSwave PhotonicsSeries A—Jan 2025
    Fyteko logoFytekoSeries B—Jan 2025
    ATB Therapeutics logoATB TherapeuticsSeries A—Nov 2024
    Profinpar Fund logoProfinpar FundUnknown—Oct 2024
    Axelera AI logoAxelera AISeries B$68MJun 2024
    Qpinch logoQpinchGrowth—May 2024
    MICLEDI MICRODISPLAYS BV logoMICLEDI MICRODISPLAYS BVSeries A—Mar 2024
    AAboleris HoldcoSeries A—Sep 2023
    Aphea.bio logoAphea.bioSeries C—Jul 2023
    CCosucraUnknown$45MJan 2023
    AAxeleraSeries A$50MDec 2022
    Axelera AI logoAxelera AISeries A$27MOct 2022
    Magnax logoMagnaxSeries B—Aug 2022
    Magnax logoMagnaxUnknown—Jan 2022
    Soil Capital logoSoil CapitalSeries B——
    D-CRBN logoD-CRBNSeries A——
    Axelera AI logoAxelera AIGrowth$250M—
    AAxeleraGrowth$250M—
    BBlue FootGrowth——
    AAxelera AI B.V.Growth$250M—
    Page 1 of 2

    Top Co-Investors

    Last updated: 7 October 2026